Kjellevold KH - Search Results

1

Farstad IN, Bofin A, Goplen AK, Kjellevold KH, Nordrum I, Sigstad E, Laerum OD. Farstad IN, et al. Among authors: kjellevold kh. Tidsskr Nor Laegeforen. 2000 Jun 10;120(15):1796-801. Tidsskr Nor Laegeforen. 2000. PMID: 10904671 Free article. Norwegian. No abstract available.

2

[Dumping syndrome following gastric surgery].

Mala T, Hewitt S, Høgestøl IK, Kjellevold K, Kristinsson JA, Risstad H. Mala T, et al. Tidsskr Nor Laegeforen. 2015 Jan 27;135(2):137-41. doi: 10.4045/tidsskr.14.0550. eCollection 2015 Jan 27. Tidsskr Nor Laegeforen. 2015. PMID: 25625992 Free article. Review. Norwegian.

3

[Dumping syndrome following gastric surgery].

Mala T, Hewitt S, Høgestøl IK, Kjellevold K, Kristinsson JA, Risstad H. Mala T, et al. Tidsskr Nor Laegeforen. 2015 Feb 24;135(4):310. doi: 10.4045/tidsskr.15.0163. eCollection 2015 Feb 24. Tidsskr Nor Laegeforen. 2015. PMID: 25707648 Free article. Norwegian. No abstract available.

4

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

Janssen EA, Øvestad IT, Skaland I, Søiland H, Gudlaugsson E, Kjellevold KH, Nysted A, Søreide JA, Baak JP. Janssen EA, et al. Among authors: kjellevold kh. Cell Oncol. 2009;31(5):335-43. doi: 10.3233/CLO-2009-0479. Cell Oncol. 2009. PMID: 19759414 Free PMC article.

5

Evaluation of 5 different labeled polymer immunohistochemical detection systems.

Skaland I, Nordhus M, Gudlaugsson E, Klos J, Kjellevold KH, Janssen EA, Baak JP. Skaland I, et al. Among authors: kjellevold kh. Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):90-6. doi: 10.1097/PAI.0b013e3181b0eaad. Appl Immunohistochem Mol Morphol. 2010. PMID: 19661787

6

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.

Steinbakk A, Skaland I, Gudlaugsson E, Janssen EA, Kjellevold KH, Klos J, Løvslett K, Fiane B, Baak JP. Steinbakk A, et al. Among authors: kjellevold kh. Am J Obstet Gynecol. 2009 Jan;200(1):78.e1-8. doi: 10.1016/j.ajog.2008.07.020. Epub 2008 Oct 30. Am J Obstet Gynecol. 2009. PMID: 18976730

7

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

Skaland I, Janssen EA, Gudlaugsson E, Klos J, Kjellevold KH, Søiland H, Baak JP. Skaland I, et al. Among authors: kjellevold kh. Breast Cancer Res Treat. 2009 Mar;114(1):39-45. doi: 10.1007/s10549-008-9980-x. Epub 2008 Mar 29. Breast Cancer Res Treat. 2009. PMID: 18373192

8

Digital image analysis improves the quality of subjective HER-2 expression scoring in breast cancer.

Skaland I, Ovestad I, Janssen EA, Klos J, Kjellevold KH, Helliesen T, Baak JP. Skaland I, et al. Among authors: kjellevold kh. Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):185-90. doi: 10.1097/PAI.0b013e318059c20c. Appl Immunohistochem Mol Morphol. 2008. PMID: 18227722

9

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

Skaland I, Janssen EA, Gudlaugsson E, Klos J, Kjellevold KH, Søiland H, Baak JP. Skaland I, et al. Among authors: kjellevold kh. Mod Pathol. 2007 Dec;20(12):1307-15. doi: 10.1038/modpathol.3800972. Epub 2007 Oct 5. Mod Pathol. 2007. PMID: 17917671 Free article.

10

Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations.

Hagen AI, Bofin AM, Ytterhus B, Maehle LO, Kjellevold KH, Myhre HO, Møller P, Lønning PE. Hagen AI, et al. Among authors: kjellevold kh. Acta Oncol. 2007;46(2):199-203. doi: 10.1080/02841860600949552. Acta Oncol. 2007. PMID: 17453369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page